| Line item | 2026-03-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $4.50M | $5.70M | $4.53M | $3.56M | $4.14M |
| R&D | $901.90K | $3.84M | $3.32M | $1.59M | $1.14M |
| SG&A | $332.39K | $1.76M | $1.21M | $1.97M | $3.00M |
| Operating Income | -$4.50M | -$5.70M | -$4.53M | -$3.56M | -$4.14M |
| Interest Expense | – | – | $107.68K | $137.46K | $496.91K |
| Tax Expense | – | – | – | – | – |
| Net Income | $1.37M | -$5.53M | -$5.00M | -$3.56M | -$4.52M |
| EPS (basic) | 0.5900 | -1.1300 | -1.1500 | -0.8200 | -1.2400 |
| EPS (diluted) | 0.5900 | -1.1300 | -1.1500 | -0.8200 | – |
| Shares (diluted) | $2.33M | $4.90M | $4.34M | $4.32M | – |